NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Yeasen Biotechnology (Shanghai) Co., Ltd.

Yeasen Biotechnology (Shanghai) Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://www.yeasenbio.com/

Last Round

Series B

Extension

Aug 26, 2021

Total Funding Raised

$93.15M

Company Overview

Yeasen Biotechnology (Shanghai) Co., Ltd. is a biotechnology company that researches, develops, manufactures, and sells biological reagents including molecules, proteins, and cells for life science research, diagnostics, and biopharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

molecular biology reagentsNGS library preparationmolecular diagnosticsrecombinant proteinsIVD reagentsenzyme engineeringbiotech raw materialslife science toolsprotein evolutionmRNA synthesisPCR reagentslab suppliesbiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yeasen Biotechnology (Shanghai) Co., Ltd. Comparables

Compare Yeasen Biotechnology (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.

Yeasen Biotechnology (Shanghai) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanjing Vazyme Biotech Co Ltd
85%
TransGen Biotech Co., Ltd.
82%
Hzymes Biotechnology Co., Ltd.
81%

Yeasen Biotechnology (Shanghai) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 26, 2021
Series BJul 16, 2021
Series AJul 1, 2020

Yeasen Biotechnology (Shanghai) Co., Ltd. Investors

Notable investors and investment history

Yeasen Biotechnology (Shanghai) Co., Ltd. investors
InvestorRounds
Huimei CapitalSeries B Extension
Legend CapitalSeries B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2021

    $39M round led by Legend Capital.

  • Jul 1, 2020

    Raised $9M in Series A funding.

Yeasen Biotechnology (Shanghai) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Yeasen Biotechnology (Shanghai) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Yeasen Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range28
Year Founded2014
Last FundingAug 26, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.